motionpharmacy.com
Has motionpharmacy.com received an FDA warning letter about GLP-1 drugs?
Yes. FDA issued motionpharmacy.com a warning letter naming semaglutide, dated Sep 10, 2025, with the FDA subject line “Unapproved New Drug/Misbranded.”
FDA records in this index name motionpharmacy.com on Sep 10, 2025.
- Websites the letters name
- motionpharmacy.com (see how each letter refers to them)
- Type named in FDA records
- Not stated
- FDA warning letters
- 1
- Drug recall reports
- 0
- Drugs named
- Semaglutide
- Latest record
- Sep 10, 2025
FDA warning letters
| Later letters FDA lists | Letter | |||
|---|---|---|---|---|
| Sep 10, 2025 | Unapproved New Drug/Misbranded | Semaglutide | None listed by FDA as of Nov 15, 2026 | fda.gov |
A warning letter states FDA’s view when it was issued; it is not a court finding, and the company may have responded since. The later-letters column repeats what FDA’s warning letter index lists for each letter.
FDA’s summary excerpts
- Sep 10, 2025: … into interstate commerce unapproved and misbranded semaglutide drug products, including injectable versions. … methods of administration. An example of unapproved semaglutide you offer for sale on www.motionpharmacy.com, … defined in 21 CFR 201.128), is listed below: Unapproved semaglutide : Marketed as: Evidence includes the claim(s): … Full letter
Websites named in the letters
Each letter below is addressed to the firm FDA names in it, not to a website. The sentence quoted is the letter’s own reference to the site, copied from the letter on fda.gov.
- motionpharmacy.com: FDA’s warning letter of Sep 10, 2025 is addressed to motionpharmacy.com. It refers to the site in these words: “… is to advise you that the United States (U.S.) Food and Drug Administration (FDA) recently reviewed your website at the Internet address www.motionpharmacy.com and has observed that your website introduces into interstate commerce misbranded and unapproved new drugs in violation of sections 301(a), …” Full letter
Drug recalls
No openFDA drug recall reports in this index.
This page lists public regulatory records as published by the issuing agency. A record is not a finding by this site. A warning letter states the agency’s view at the time it was issued; companies may have responded or corrected the issue since. Follow each link for the original document and any close-out letter. Report an error or add a company response.
Sources
Records last pulled Nov 15, 2026. Every entry links to the original public record.